Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)

Glaucoma Clinical Trial

Official title: Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1)

Status Terminated

Clinical Trial Summary

This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in African-American descent volunteers. The main goal of the study is to provide the range of these structural parameters in normal eyes.

Clinical Trial Description

This prospective, single-arm clinical multicenter study intends to measure normal structural parameters of the optic nerve head, the peripapillary retinal nerve fiber layer, and the macula using the Heidelberg Spectralis OCT device. This study is conducted in African-American descent volunteers. The main goal of the study is to provide the range of these structural parameters in normal eyes. The study will include at least 240 normal volunteers; up to 10 study sites will recruit subjects. Overall an approximately equal age distribution from 18 to 90 years and an approximately equal number of females and males will be enrolled (approximately 40-60% females in each age group). All subjects will undergo Spectralis OCT imaging, biometric and ophthalmoscopic examination, disc photography and visual field testing in one single visit, if possible. Repeated perimetry or Spectralis scans may be performed at a second visit within 30 days of the initial visit. All examinations performed on the subjects are non-significant risk procedures. ;

Related Conditions & MeSH terms

• Glaucoma

• NCT number: NCT02785029
• Study type: Interventional
• Source: Heidelberg Engineering GmbH
• Status: Terminated
• Phase: N/A
• Start date: June 2016
• Completion date: July 2023